NSC |
Compound |
Enrichment |
Correlation |
NSC 722779 |
dabequine |
0.0286383688883668 |
0.11807161 |
NSC 724562 |
11-(3'Aminopropylidene)-5,6-dihydro-5-oxo-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline |
0.0286383688883668 |
0.3853501 |
NSC 725202 |
Null |
0.0286383688883668 |
0.49552202 |
NSC 726444 |
4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.0286383688883668 |
0.45079125 |
NSC 726718 |
3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid |
0.0286383688883668 |
0.58288742 |
NSC 727759 |
1-benzyl-3-chloro-4-(3-chloroanilino)-2,5-dihydro-1H-2,5-pyr roledione |
0.0286383688883668 |
0.61589572 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0286383688883668 |
0.45068267 |
NSC 728512 |
1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine |
0.0286383688883668 |
0.31865373 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.0286383688883668 |
0.49518084 |
NSC 744231 |
Null |
0.0286383688883668 |
0.2828653 |